Medical management of first-trimester abortion

Contraception

Volumn 89, Issue 3, 2014, Pages 148-161

  Creinin, Mitchell D ^a   Grossman, Daniel A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; IBUPROFEN; LETROZOLE; METHOTREXATE; MIFEPRISTONE; MISOPROSTOL; TAMOXIFEN;

ADVERSE OUTCOME; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BODY TEMPERATURE DISORDER; CLINICAL EFFECTIVENESS; CONTRACEPTION; DIARRHEA; DIZZINESS; DRUG APPROVAL; DRUG CHOICE; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; EVIDENCE BASED PRACTICE; FAMILY PLANNING; FEMALE FERTILITY; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; FOOD AND DRUG ADMINISTRATION; GESTATIONAL AGE; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; MEDICAL ABORTION; MULTICENTER STUDY (TOPIC); NAUSEA; PATIENT COUNSELING; PATIENT IDENTIFICATION; PATIENT PREFERENCE; PRACTICE GUIDELINE; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; SURGICAL ABORTION; SYSTEMATIC REVIEW (TOPIC); TERATOGENICITY; TRANSVAGINAL ECHOGRAPHY; TREATMENT INDICATION; VOMITING;

ABORTIFACIENT AGENTS; ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; CHORIONIC GONADOTROPIN; COUNSELING; EVIDENCE-BASED MEDICINE; FEMALE; GESTATIONAL AGE; HUMANS; MIFEPRISTONE; MISOPROSTOL; PREGNANCY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84896523068     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2014.01.016     Document Type: Article

References (112)

1. K. Pazol, A.A. Creanga, S.B. Zane, K.D. Burley, and D.J. Jamieson Abortion surveillance-United States, 2009. Centers for Disease Control and Prevention (CDC) MMWR Surveill Summ 61 SS-8 2012 1 44 (Level II-3)
2. A. Gravanis, G. Schaison, M. George, J. de Brux, P.G. Satyaswaroop, and E.E. Baulieu et al. Endometrial and pituitary responses to the steroidal antiprogestin RU 486 in postmenopausal women J Clin Endocrinol Metab 60 1985 156 163 (Level III) (Pubitemid 15194664)
3. M.L. Swahn, and M. Bygdeman The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin Br J Obstet Gynaecol 95 1988 126 134 (Level II-3)
4. E. Johannisson, M. Oberholzer, M.L. Swahn, and M. Bygdeman Vascular changes in the human endometrium following the administration of the progesterone antagonist RU 486 Contraception 39 1989 103 117 (Level III) (Pubitemid 19022942)
5. M.D. Creinin, C.A. Schreiber, P. Bednarek, H. Lintu, M.S. Wagner, and L.A. Meyn Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial. Medical Abortion at the Same Time (MAST) Study Trial Group. Obstet Gynecol 109 2007 885 894 (Level I) (Pubitemid 46559076)
6. R.D. Clark Glucocorticoid receptor antagonists Curr Top Med Chem 8 2008 813 838 (Level III) (Pubitemid 351982568)
7. I.M. Spitz Mifepristone: where do we come from and where are we going? Clinical development over a quarter of a century Contraception 82 2010 442 452 (Level III)
8. R. Allen, and B.M. O'Brien Uses of misoprostol in obstetrics and gynecology Rev Obstet Gynecol 2 2009 159 168 (Level III)
9. M. Zieman, S.K. Fong, N.L. Benowitz, D. Banskter, and P.D. Darney Absorption kinetics of misoprostol with oral or vaginal administration Obstet Gynecol 90 1997 88 92 (Level I) (Pubitemid 27272963)
10. K.G. Danielsson, L. Marions, A. Rodriguez, B.W. Spur, P.Y. Wong, and M. Bygdeman Comparison between oral and vaginal administration of misoprostol on uterine contractility Obstet Gynecol 93 1999 275 280 (Level I) (Pubitemid 29068106)
11. O.S. Tang, H. Schweer, H.W. Seyberth, S.W. Lee, and P.C. Ho Pharmacokinetics of different routes of administration of misoprostol Hum Reprod 17 2002 332 336 (Level I) (Pubitemid 34168436)
12. E.A. Schaff, R. DiCenzo, and S.L. Fielding Comparison of misoprostol plasma concentrations following buccal and sublingual administration Contraception 71 2005 22 25 (Level II-3) (Pubitemid 41583143)
13. K.R. Meckstroth, A.K. Whitaker, S. Bertisch, A.B. Goldberg, and P.D. Darney Misoprostol administered by epithelial routes: drug absorption and uterine response Obstet Gynecol 108 2006 582 590 (Level I) (Pubitemid 44337099)
14. J.K. Jain, C. Dutton, B. Harwood, K.R. Meckstroth, and D.R. Mishell Jr. A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy Hum Reprod 17 2002 1477 1482 (Level I) (Pubitemid 34661795)
15. J. Blum, S. Raghavan, R. Dabash, N. Ngoc, H. Chelli, and S. Hajri et al. Comparison of misoprostol-only and combined mifepristone-misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam Int J Gynaecol Obstet 118 2012 166 171 (Level I)
16. M.D. Creinin Medical abortion regimens: historical context and overview Am J Obstet Gynecol 183 2000 S3 S9 (Level III)
17. J. Benson, K.A. Clark, A. Gerhardt, L. Randall, and S. Dudley Early abortion services in the United States: a provider survey Contraception 67 2003 287 294 (Level III) (Pubitemid 36398513)
18. J.A. DeLoia, A.M. Stewart-Akers, and M.D. Creinin Effects of methotrexate on trophoblast proliferation and local immune responses Hum Reprod 13 1998 1063 1069 (Level III) (Pubitemid 28239221)
19. E.R. Wiebe Tamoxifen compared to methotrexate when used with misoprostol for abortion Contraception 59 1999 265 270 (Level I) (Pubitemid 29361483)
20. J.K. Jain, K.R. Meckstroth, M. Park, and D.R. Mishell Jr. A comparison of tamoxifen and misoprostol to misoprostol alone for early pregnancy termination Contraception 60 1999 353 356 (Level I) (Pubitemid 30133224)
21. V.C. Lee, E.H. Ng, W.S. Yeung, and P.C. Ho Misoprostol with or without letrozole pretreatment for termination of pregnancy: a randomized controlled trial Obstet Gynecol 117 2011 317 323 (Level I)
22. T.W. Yeung, V.C. Lee, E.H. Ng, and P.C. Ho A pilot study on the use of a 7-day course of letrozole followed by misoprostol for the termination of early pregnancy up to 63 days Contraception 86 2012 763 769 (Level III)
23. Danco Laboratories Mifeprex® (mifepristone) tablets, 200 mg: prescribing information. New York (NY): Danco Laboratories Available at: http://www.earlyoptionpill.com/userfiles/file/Mifeprex%20Labeling%204-22-09- Final-doc.pdf 2009 Retrieved May 16, 2013. (Level III)
24. I.M. Spitz, C.W. Bardin, L. Benton, and A. Robbins Early pregnancy termination with mifepristone and misoprostol in the United States N Engl J Med 338 1998 1241 1247 (Level II-3) (Pubitemid 28216577)
25. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial. World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation BJOG 107 2000 524 530 (Level 1)
26. E. Aubeny, R. Peyron, C.L. Turpin, M. Renault, V. Targosz, and L. Silvestre et al. Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol [published erratum appears in Int J Fertil Menopausal Stud 1996;41:56] Int J Fertil Menopausal Stud 40 Suppl. 2 1995 85 91 (Level II-3)
27. M.D. Creinin, and I.M. Spitz Use of various ultrasonographic criteria to evaluate the efficacy of mifepristone and misoprostol for medical abortion Am J Obstet Gynecol 181 1999 1419 1424 (Level III) (Pubitemid 30021887)
28. R. Peyron, E. Aubeny, V. Targosz, L. Silvestre, M. Renault, and F. Elkik et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol N Engl J Med 328 1993 1509 1513 (Level II-3) (Pubitemid 23147779)
29. Kulier R, Kapp N, Gulmezoglu AM, Hofmeyr GJ, Cheng L, Campana A. Medical methods for first trimester abortion. Cochrane Database of Systematic Reviews 2011, Issue 11. Art. No.: CD002855. DOI: 10.1002/14651858.CD002855.pub4. (Meta-analysis).
30. E.A. Schaff Mifepristone: ten years later Contraception 81 2010 1 7 (Level III)
31. M.D. Creinin, M.C. Fox, S. Teal, A. Chen, E.A. Schaff, and L.A. Meyn A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion. MOD Study Trial Group. Obstet Gynecol 103 2004 851 859 (Level I) (Pubitemid 40458983)
32. B. Winikoff, I.G. Dzuba, M.D. Creinin, W.A. Crowden, A.B. Goldberg, and J. Gonzales et al. Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial Obstet Gynecol 112 2008 1303 1310 (Level I)
33. H. von Hertzen, N.T. Huong, G. Piaggio, M. Bayalag, E. Cabezas, and A.H. Fang et al. Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial. WHO Research Group on Postovulatory Methods of Fertility Regulation. BJOG 117 2010 1186 1196 (Level I)
34. T.D. Ngo, M.H. Park, H. Shakur, and C. Free Comparative effectiveness, safety and acceptability of medical abortion at home and in a clinic: a systematic review Bull World Health Organ 89 2011 360 370 (Meta-analysis)
35. S. Raghavan, T. Tsereteli, A. Kamilov, D. Kurbanbekova, D. Yusupov, and F. Kasimova et al. Acceptability and feasibility of the use of 400mg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan Eur J Contracept Reprod Health Care 18 2013 104 111 (Level II-3)
36. R.C. Henshaw, S.A. Naji, I.T. Russell, and A.A. Templeton Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment BMJ 307 1993 714 717 (Level II-3) (Pubitemid 23275360)
37. M.D. Creinin Randomized comparison of efficacy, acceptability and cost of medical versus surgical abortion Contraception 62 2000 117 124 (Level I)
38. C. Rorbye, M. Norgaard, and L. Nilas Medical versus surgical abortion: comparing satisfaction and potential confounders in a partly randomized study Hum Reprod 20 2005 834 838 (Level II-3 (Pubitemid 40425518)
39. P.C. Ho Women's perceptions on medical abortion Contraception 74 2006 11 15 (Level III) (Pubitemid 43870272)
40. E.A. Schaff, L.S. Stadalius, S.H. Eisinger, and P. Franks Vaginal misoprostol administered at home after mifepristone (RU486) for abortion J Fam Pract 44 1997 353 360 (Level III) (Pubitemid 27174895)
41. E.A. Schaff, S.H. Eisinger, L.S. Stadalius, P. Franks, B.Z. Gore, and S. Poppema Low-dose mifepristone 200 mg and vaginal misoprostol for abortion Contraception 59 1999 1 6 (Level II-3) (Pubitemid 29174410)
42. E. Wiebe, S. Dunn, E. Guilbert, F. Jacot, and L. Lugtig Comparison of abortions induced by methotrexate or mifepristone followed by misoprostol Obstet Gynecol 99 2002 813 819 (Level I) (Pubitemid 34442460)
43. H. Honkanen, G. Piaggio, H. Hertzen, G. Bartfai, R. Erdenetungalag, and K. Gemzell-Danielsson et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. WHO Research Group on Post-Ovulatory Methods for Fertility Regulation. BJOG 111 2004 715 725 (Level I) (Pubitemid 38869761)
44. J. Chai, C.Y. Wong, and P.C. Ho A randomized clinical trial comparing the short-term side effects of sublingual and buccal routes of misoprostol administration for medical abortions up to 63 days' gestation Contraception 87 2013 480 485 (Level I)
45. M.D. Creinin, and K.G. Danielsson Medical abortion in early pregnancy M. Paul, E.S. Lichtenberg, L. Borgatta, D.A. Grimes, P.G. Stubblefield, M.D. Creinin, Management of unintended and abnormal pregnancy: comprehensive abortion care 2009 Wiley-Blackwell Hoboken (NJ) 111 134 (Level III)
46. B. Winikoff, I. Sivin, K.J. Coyaji, E. Cabezas, B. Xiao, and S. Gu et al. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion Am J Obstet Gynecol 176 1997 431 437 (Level II-3) (Pubitemid 27107935)
47. P.W. Ashok, G.C. Penney, G.M. Flett, and A. Templeton An effective regimen for early medical abortion: a report of 2000 consecutive cases Hum Reprod 13 1998 2962 2965 (Level II-3) (Pubitemid 28482759)
48. A. Livshits, R. Machtinger, L.B. David, M. Spira, A. Moshe-Zahav, and D.S. Seidman Ibuprofen and paracetamol for pain relief during medical abortion: a double-blind randomized controlled study Fertil Steril 91 2009 1877 1880 (Level I)
49. M.D. Creinin, and T. Shulman Effect of nonsteroidal anti-inflammatory drugs on the action of misoprostol in a regimen for early abortion Contraception 56 1997 165 168 (Level III) (Pubitemid 27450827)
50. E.G. Raymond, M.A. Weaver, K.S. Louie, G. Dean, L. Porsch, and E.S. Lichtenberg et al. Prophylactic compared with therapeutic ibuprofen analgesia in first-trimester medical abortion: a randomized controlled trial Obstet Gynecol 122 2013 558 564 (Level I)
51. E.G. Raymond, C. Shannon, M.A. Weaver, and B. Winikoff First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review Contraception 87 2013 26 37 (Level III)
52. M.F. Reeves, A. Kudva, and M.D. Creinin Medical abortion outcomes after a second dose of misoprostol for persistent gestational sac Contraception 78 2008 332 335 (Level III)
53. M.D. Creinin, E. Vittinghoff, L. Keder, P.D. Darney, and G. Tiller Methotrexate and misoprostol for early abortion: a multicenter trial. I. Safety and efficacy. Contraception 53 1996 321 327 (Level II-3) (Pubitemid 26001013)
54. K. Cleland, M.D. Creinin, D. Nucatola, M. Nshom, and J. Trussell Significant adverse events and outcomes after medical abortion Obstet Gynecol 121 2013 166 171 (Level III)
55. R.H. Allen, C. Westhoff, L. De Nonno, S.L. Fielding, and E.A. Schaff Curettage after mifepristone-induced abortion: frequency, timing, and indications Obstet Gynecol 98 2001 101 106 (Level III) (Pubitemid 32622772)
56. J.L. Hayes, S.L. Achilles, M.D. Creinin, and M.F. Reeves Outcomes of medical abortion through 63 days in women with twin gestations Contraception 84 2011 505 507 (Level III)
57. E. Hakim-Elahi, H.M. Tovell, and M.S. Burnhill Complications of first-trimester abortion: a report of 170,000 cases Obstet Gynecol 76 1990 129 135 (Level II-3) (Pubitemid 20205234)
58. P.W. Ashok, A. Templeton, P.T. Wagaarachchi, and G.M. Flett Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases BJOG 109 2002 1281 1289 (Level II-3) (Pubitemid 36164756)
59. O.S. Tang, C.C. Chan, E.H. Ng, S.W. Lee, and P.C. Ho A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation Hum Reprod 18 2003 2315 2318 (Level I) (Pubitemid 37427810)
60. E. Chong, T. Tsereteli, N.N. Nguyen, and B. Winikoff A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion Contraception 86 2012 251 256 (Level I)
61. H. Hamoda, P.W. Ashok, G.M. Flett, and A. Templeton Medical abortion at 9-13 weeks' gestation: a review of 1076 consecutive cases Contraception 71 2005 327 332 (Level II-3) (Pubitemid 40602308)
62. Q.J. Chen, S.P. Hou, C. Meads, Y.M. Huang, Q.Q. Hong, and H.P. Zhu et al. Mifepristone in combination with prostaglandins for termination of 10-16 weeks' gestation: a systematic review. EBM-CONNECT Collaboration. Eur J Obstet Gynecol Reprod Biol 159 2011 247 254 (Meta-analysis)
63. H. Hamoda, P.W. Ashok, G.M. Flett, and A. Templeton A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation BJOG 112 2005 1102 1108 (Level I) (Pubitemid 41632666)
64. B. Winikoff, I.G. Dzuba, E. Chong, A.B. Goldberg, E.S. Lichtenberg, and C. Ball et al. Extending outpatient medical abortion services through 70 days of gestational age Obstet Gynecol 120 2012 1070 1076 (Level II-3)
65. C. Shannon, L.P. Brothers, N.M. Philip, and B. Winikoff Infection after medical abortion: a review of the literature Contraception 70 2004 183 190 (Level III) (Pubitemid 39119979)
66. A.L. Cohen, J. Bhatnagar, S. Reagan, S.B. Zane, M.A. D'Angeli, and M. Fischer et al. Toxic shock associated with Clostridium sordellii and Clostridium perfringens after medical and spontaneous abortion Obstet Gynecol 110 2007 1027 1033 (Level III) (Pubitemid 350059407)
67. C.S. Ho, J. Bhatnagar, A.L. Cohen, J.K. Hacker, S.B. Zane, and S. Reagan et al. Undiagnosed cases of fatal Clostridium-associated toxic shock in Californian women of childbearing age Am J Obstet Gynecol 2009 459.e1 459.e7 (Level III)
68. M. Fjerstad, J. Trussell, I. Sivin, E.S. Lichtenberg, and V. Cullins Rates of serious infection after changes in regimens for medical abortion N Engl J Med 361 2009 145 151 (Level II-3)
69. H. Bracken, W. Clark, E.S. Lichtenberg, S.M. Schweikert, J. Tanenhaus, and A. Barajas et al. Alternatives to routine ultrasound for eligibility assessment prior to early termination of pregnancy with mifepristone-misoprostol BJOG 118 2011 17 23 (Level II-3)
70. Ectopic pregnancy-United States, 1988-1989. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep 41 1992 591 594 (Level II-3)
71. S.K. Van Den Eeden, J. Shan, C. Bruce, and M. Glasser Ectopic pregnancy rate and treatment utilization in a large managed care organization Obstet Gynecol 105 2005 1052 1057 (Level II-3) (Pubitemid 40571025)
72. D.B. Stulberg, L.R. Cain, I. Dahlquist, and D.S. Lauderdale Ectopic pregnancy rates in the Medicaid population Am J Obstet Gynecol 208 2013 274.e1 274.e7 (Level II-3)
73. J. Edwards, and M.D. Creinin Surgical abortion for gestations of less than 6 weeks Curr Probl Obstet Gynecol Fertil 20 1997 11 19 (Level II-2)
74. A. Ulmann, L. Silvestre, L. Chemama, Y. Rezvani, M. Renault, and C.J. Aguillaume et al. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women Acta Obstet Gynecol Scand 71 1992 278 283 (Level II-3)
75. P.A. Lohr, M.F. Reeves, and M.D. Creinin A comparison of transabdominal and transvaginal ultrasonography for determination of gestational age and clinical outcomes in women undergoing early medical abortion Contraception 81 2010 240 244 (Level II-3)
76. M.D. Creinin, C. Potter, M. Holovanisin, L. Janczukiewicz, H.C. Pymar, and J.L. Schwartz et al. Mifepristone and misoprostol and methotrexate/ misoprostol in clinical practice for abortion Am J Obstet Gynecol 188 2003 664 669 (Level II-3) (Pubitemid 36332431)
77. L. Prine, R. Lesnewski, N. Berley, and M. Gold Medical abortion in family practice: a case series J Am Board Fam Pract 16 2003 290 295 (Level III)
78. R. Haimov-Kochman, R. Arbel, Y. Sciaky-Tamir, A. Brzezinski, N. Laufer, and S. Yagel Risk factors for unsuccessful medical abortion with mifepristone and misoprostol Acta Obstet Gynecol Scand 86 2007 462 466 (Level II-3) (Pubitemid 46747699)
79. B. Rossi, M.D. Creinin, and L.A. Meyn Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion Contraception 70 2004 313 317 (Level II-3) (Pubitemid 39286767)
80. L.K. Perriera, M.F. Reeves, B.A. Chen, H.L. Hohmann, J. Hayes, and M.D. Creinin Feasibility of telephone follow-up after medical abortion Contraception 81 2010 143 149 (Level II-3)
81. D. Grossman, and K. Grindlay Alternatives to ultrasound for follow-up after medication abortion: a systematic review Contraception 83 2011 504 510 (Level III)
82. M.F. Reeves, M.C. Fox, P.A. Lohr, and M.D. Creinin Endometrial thickness following medical abortion is not predictive of subsequent surgical intervention Ultrasound Obstet Gynecol 34 2009 104 109 (Level III)
83. C. Fiala, P. Safar, M. Bygdeman, and K. Gemzell-Danielsson Verifying the effectiveness of medical abortion; ultrasound versus hCG testing Eur J Obstet Gynecol Reprod Biol 109 2003 190 195 (Level III) (Pubitemid 36814085)
84. S.T. Cameron, A. Glasier, H. Dewart, A. Johnstone, and A. Burnside Telephone follow-up and self-performed urine pregnancy testing after early medical abortion: a service evaluation Contraception 86 2012 67 73 (Level II-3)
85. E.M. Godfrey, A. Anderson, S.L. Fielding, L. Meyn, and M.D. Creinin Clinical utility of urine pregnancy assays to determine medical abortion outcome is limited Contraception 75 2007 378 382 (Level II-3) (Pubitemid 46551079)
86. D. Grossman, K. Berdichevsky, F. Larrea, and J. Beltran Accuracy of a semi-quantitative urine pregnancy test compared to serum beta-hCG measurement: a possible screening tool for ongoing pregnancy after medication abortion Contraception 76 2007 101 104 (Level II-3) (Pubitemid 47080983)
87. I. Dayananda, R. Maurer, J. Fortin, and A.B. Goldberg Medical abortion follow-up with serum human chorionic gonadotropin compared with ultrasonography: a randomized controlled trial Obstet Gynecol 121 2013 607 613 (Level I)
88. E.L. Horning, B.A. Chen, L.A. Meyn, and M.D. Creinin Comparison of medical abortion follow-up with serum human chorionic gonadotropin testing and in-office assessment Contraception 85 2012 402 407 (Level II-3)
89. J. Blum, T. Shochet, K. Lynd, E.S. Lichtenberg, D. Fischer, and M. Arnesen et al. Can at-home semi-quantitative pregnancy tests serve as a replacement for clinical follow-up of medical abortion? A US study Contraception 86 2012 757 762 (Level II-3)
90. E.A. Schaff, S.L. Fielding, C. Westhoff, C. Ellertson, S.H. Eisinger, and L.S. Stadalius et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial [published erratum appears in JAMA 2000;284:2597] JAMA 284 2000 1948 1953 (Level I)
91. C. Arvidsson, M. Hellborg, and K. Gemzell-Danielsson Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone Eur J Obstet Gynecol Reprod Biol 123 2005 87 91 (Level I) (Pubitemid 41563100)
92. S.K. Yip, A.O. Tse, C.J. Haines, and T.K. Chung Misoprostol's effect on uterine arterial blood flow and fetal heart rate in early pregnancy Obstet Gynecol 95 2000 232 235 (Level III) (Pubitemid 30045645)
93. W. Fonseca, A.J. Alencar, F.S. Mota, and H.L. Coelho Misoprostol and congenital malformations Lancet 338 1991 56 (Level III)
94. C.H. Gonzalez, F.R. Vargas, A.B. Perez, C.A. Kim, D. Brunoni, and M.J. Marques-Dias et al. Limb deficiency with or without Mobius sequence in seven Brazilian children associated with misoprostol use in the first trimester of pregnancy Am J Med Genet 47 1993 59 64 (Level III) (Pubitemid 23221528)
95. M.J. Marques-Dias, C.H. Gonzalez, and S. Rosemberg Mobius sequence in children exposed in utero to misoprostol: neuropathological study of three cases Birth Defects Res A Clin Mol Teratol 67 2003 1002 1007 (Level III) (Pubitemid 38018044)
96. A.L. Pastuszak, L. Schuler, C.E. Speck-Martins, K.E. Coelho, S.M. Cordello, and F. Vargas et al. Use of misoprostol during pregnancy and Mobius' syndrome in infants N Engl J Med 338 1998 1881 1885 (Level II-3) (Pubitemid 28287860)
97. E.R. Wiebe Abortion induced with methotrexate and misoprostol: a comparison of various protocols Contraception 55 1997 159 163 (Level II-3) (Pubitemid 27180391)
98. K. MacDonald, W.V. Norman, and O. Popescu New anomalies due to methotrexate and misoprostol exposure in early pregnancy Int J Gynaecol Obstet 122 2013 267 268 (Level III)
99. M.D. Creinin Conception rates after abortion with methotrexate and misoprostol Int J Gynaecol Obstet 65 1999 183 188 (Level III)
100. P.G. Steinhoff, R.G. Smith, J.A. Palmore, M. Diamond, and C.S. Chung Women who obtain repeat abortions: a study based on record linkage Fam Plann Perspect 11 1979 30 38 (Level II-3)
101. A. Chen, W. Yuan, O. Meirik, X. Wang, S.Z. Wu, and L. Zhou et al. Mifepristone-induced early abortion and outcome of subsequent wanted pregnancy Am J Epidemiol 160 2004 110 117 (Level II-2) (Pubitemid 38962996)
102. C. Oliver-Williams, M. Fleming, K. Monteath, A.M. Wood, and G.C. Smith Changes in association between previous therapeutic abortion and preterm birth in Scotland, 1980 to 2008: a historical cohort study PLoS Med 10 2013 e1001481 (Level II-3)
103. J. Yarnall, Y. Swica, and B. Winikoff Non-physician clinicians can safely provide first trimester medical abortion Reprod Health Matters 17 2009 61 69 (Level III)
104. I.K. Warriner, D. Wang, N.T. Huong, K. Thapa, A. Tamang, and I. Shah et al. Can midlevel health-care providers administer early medical abortion as safely and effectively as doctors? A randomised controlled equivalence trial in Nepal Lancet 377 2011 1155 1161 (Level I)
105. D. Grossman, K. Grindlay, T. Buchacker, K. Lane, and K. Blanchard Effectiveness and acceptability of medical abortion provided through telemedicine Obstet Gynecol 118 2011 296 303 (Level II-3)
106. D.A. Grossman, K. Grindlay, T. Buchacker, J.E. Potter, and C.P. Schmertmann Changes in service delivery patterns after introduction of telemedicine provision of medical abortion in Iowa Am J Public Health 103 2013 73 78 (Level II-3)
107. U. S. Medical Eligibility Criteria for Contraceptive Use, 2010. Centers for Disease Control and Prevention (CDC) MMWR Recomm Rep 59 RR-4 2010 1 86 (Level III)
108. S. Mittal Contraception after medical abortion Contraception 74 2006 56 60 (Level III) (Pubitemid 43866058)
109. Understanding and using the U.S. selected practice recommendations for contraceptive use, 2013. Committee Opinion No. 577. American College of Obstetricians and Gynecologists Obstet Gynecol 122 2013 1132 1133 (Level III)
110. N. Shimoni, A. Davis, M.E. Ramos, L. Rosario, and C. Westhoff Timing of copper intrauterine device insertion after medical abortion: a randomized controlled trial Obstet Gynecol 118 2011 623 628 (Level I)
111. I. Saav, O. Stephansson, and K. Gemzell-Danielsson Early versus delayed insertion of intrauterine contraception after medical abortion - a randomized controlled trial PLoS One 7 2012 e48948 (Level I)
112. P.H. Bednarek, M.D. Creinin, M.F. Reeves, C. Cwiak, E. Espey, and J.T. Jensen Immediate versus delayed IUD insertion after uterine aspiration. Post-Aspiration IUD Randomization (PAIR) Study Trial Group N Engl J Med 364 2011 2208 2217 (Level I)